Skip to main content
Immunology logoLink to Immunology
. 2018 Feb 2;153(3):397. doi: 10.1111/imm.12875

Corrigendum

PMCID: PMC5795185  PMID: 29392768

In the following article1 there is an error in the figure S1 caption:

Figure S1. Validation of DNA immunization protocol. Splenocytes from C57BL/6 (a) and BALB/c (b) mice immunized with the pVAX‐Der p 2 construct were screened using the interferon‐γ (IFN‐γ) ELISPOT assay with 15‐mer overlapping peptides (10‐overlaps) spanning the sequence of the Der p 2 protein. Subsequent screening of CD4 or CD8 T‐cell‐depleted splenocytes using the IFN‐γ ELISPOT with the peptides containing the identified epitopes were conducted for C57BL/6 (c) and BALB/ c mice (d) immunized with the pVAX‐Der p 2 construct.

The figure S1 caption should have read:

Figure S1. Validation of DNA immunization protocol. Splenocytes from BALB/c (a) and C57BL/6 (c) and mice immunized with the pVAX‐Der p 2 construct were screened using the interferon‐γ (IFN‐γ) ELISPOT assay with 15‐mer overlapping peptides (10‐overlaps) spanning the sequence of the Der p 2 protein. Subsequent screening of CD4 or CD8 T‐cell‐depleted splenocytes using the IFN‐γ ELISPOT with the peptides containing the identified epitopes were conducted for BALB/c (b) and C57BL/6 (d) mice immunized with the pVAX‐Der p 2 construct.

Reference

  • 1. Wong KH, Zhou Q, Prabhu N, Furuhashi K, Chua YL, Grotenbreg GM, Kemeny DM. Blomia tropicalis allergen 5 (Blo t 5) T‐cell epitopes and their ability to suppress the allergic immune response. Immunol 2017; 152:344–55. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES